Vernon Bernardino

Vernon Bernardino has a strong background in the finance industry, particularly in the biotechnology sector. Vernon began their career at UBS as an Associate Analyst before moving on to work at Rodman & Renshaw LLC as a Senior Analyst. Vernon then joined Dawson James Securities as a Senior Research Analyst, where they focused on biotechnology equity research and helped companies raise over $15 million in follow-on offerings. Bernardino also worked as a Senior Analyst at Global Hunter Securities, covering emerging biotechnology companies.

In 2012, they became the Managing Director of Equity Research at Brinson Patrick Securities Corporation, a boutique investment bank. Bernardino went on to found Oceros Advisors LP in 2009, a consulting group specializing in nontraditional strategic advisory services for the biopharmaceutical industry. Vernon provided valuable expertise in asset and product portfolio review, market assessment, and competitive intelligence.

Bernardino's career also includes roles at MLV & Co. as a Senior Research Analyst, FBR & Co. as a Senior Research Analyst and Senior Vice President, and Seaport Global Securities as a Managing Director of Healthcare. Currently, they hold the position of Managing Director at H.C. Wainwright & Co., LLC, a full-service investment bank offering corporate finance and strategic advisory services.

Vernon Bernardino obtained a Master of Business Administration (MBA) with a specialization in Finance from the University of San Diego, where they attended from 1998 to 2001. Prior to that, they pursued their undergraduate studies in Biological Sciences at Rutgers University. However, specific information regarding the start and end dates of their time at Rutgers University is not provided.